Product Information
GALANTAMINE HBR 8 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.4371 per EA under NDC 70436000506. Its NADAC has been published 381 times since Jan 31, 2018.
FDA first approved this application on Feb 6, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436000506
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077604FDA Approved
2/6/2009
TE Code
AB
On Market Since
8/2/2017
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE HBR 8 MG TABLET has been published 381 times since Jan 31, 2018, and over the history we have for it it has declined 63.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4371 per EA |
|---|---|
| All-time high | $1.1958 (Feb 14, 2018) |
| All-time low | $0.3390 (Jan 22, 2025) |
| Median price | $0.5260 |
| Average price | $0.5492 |
| Largest weekly change | +57.2% (Jun 20, 2018) |
| Weeks tracked | 381 |
| Tracking since | Jan 31, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+6.9%
5Y
-30.9%
All
-63.4%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GALANTAMINE HBR 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 8 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.4371 per EA (NDC 70436000506), effective May 14, 2025.
How has the price of GALANTAMINE HBR 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for GALANTAMINE HBR 8 MG TABLET has declined 63.4%. It has been tracked across 381 weekly CMS publications since Jan 31, 2018.
What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 8 MG TABLET?
Since Jan 31, 2018, the NADAC for GALANTAMINE HBR 8 MG TABLET has ranged from a low of $0.3390 (Jan 22, 2025) to a high of $1.1958 (Feb 14, 2018), with a median of $0.5260 per EA.
Are there cheaper alternatives to GALANTAMINE HBR 8 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GALANTAMINE HBR 8 MG TABLET, is $0.4007 per EA — about 8% below GALANTAMINE HBR 8 MG TABLET.
Who manufactures GALANTAMINE HBR 8 MG TABLET?
GALANTAMINE HBR 8 MG TABLET (NDC 70436000506) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.